Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Where Viral Infections Meet Rheumatic Disease

Jason Liebowitz, MD, FACR  |  November 21, 2023

Updates from the ACR Convergence 2023 Review Course, part 8

SAN DIEGO—The pre-conference Review Course at ACR Convergence 2023, held Saturday, Nov. 11, and moderated by Noelle Rolle, MBBS, assistant professor in the Division of Rheumatology, associate program director of the Rheumatology Fellowship at the Medical College of Georgia, Augusta University, and Julia Schwartzmann-Morris, MD, associate professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, N.Y., tackled numerous important topics in rheumatology. Here, we report on the presentation by Leonard Calabrese, DO, vice chair of the Cleveland Clinic’s Department of Rheumatic and Immunologic Diseases and director of the Cleveland Clinic’s RJ Fasenmyer Center for Clinical Immunology, Cleveland.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Calabrese spoke about the intersection of viral infections and rheumatic diseases. Viral infections are a common cause of acute arthritis and, in general, tend to be short lived and are not usually associated with significant articular inflammation. Due to the prevalence of various viral infections across the globe, any patient with signs of early inflammatory arthritis (i.e., symptoms that have not yet lasted six weeks) should be evaluated for a possible infectious etiology.

Dr. Calabrese

Parvovirus B19 infection in children commonly results in a slapped cheek rash, and a minority of pediatric patients have joint swelling. In adults, Parvovirus B19 infection may not cause a rash, or the rash can be atypical, and these patients commonly experience arthritis, which is more often polyarticular rather than migratory. The synovitis associated with this infection is minimal and is typically transient, lasting one to two weeks. Patients with this infection can also experience other manifestations, such as small vessel vasculitis and anemia, and patients can even generate autoantibodies seen in rheumatic conditions. Thus, in patients with an acute inflammatory arthritis, consider parvovirus B19 infection as a possible cause, even when autoantibodies are present.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Location Specific

Dr. Calabrese noted that, in individuals with arthritis after returning from travel (especially to foreign or exotic locations), the rheumatologist must consider the possibility of various bacterial, parasitic or viral infections. Included in this evaluation should be pathogens that can cause sexually transmitted infections. The assessment for specific pathogens should be based on geographic areas of travel and the epidemiology of certain organisms in those areas.

Chikungunya virus is of particular interest because nearly all patients will be symptomatic after infection, with symptoms that can include fever, myalgias and intense arthralgias. The condition is self-limiting in most patients, but a second phase of the illness can sometimes occur and last for several months.

Page: 1 2 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2023

Related Articles

    Meet the HEP C Challenge

    December 1, 2008

    Keep a hepatitis C virus infection from hindering RA treatment

    Hepatitis Reaction with Rituximab Sparks Drug Safety Alert

    January 1, 2015

    The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation

    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    June 15, 2017

    Rheumatologists treating HIV patients in 2017 must think through many important factors as this population ages. As we continue to learn, rheumatologists must consider important drug–drug interactions, relatively uncommon rheumatological presentations of HIV, as well as specific diagnostic challenges. Working closely with infectious disease specialists is the best way to achieve optimum care for this…

    Hepatitis Virus, Rheumatic Disease Connection Explored

    July 14, 2017

    CHICAGO—Leonard H. Calabrese, DO, professor of medicine at Cleveland Clinic in Ohio, presented on emerging concepts of viral infections and rheumatic disease at the ACR’s State-of-the-Art Clinical Symposium in April. “We are at a pivotal point in rheumatology in understanding the relationship between viruses and rheumatic disease,” began Dr. Calabrese. “It’s a very exciting time.” Dr. Calabrese…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences